Xelion Webchat <= 9.1.0 - Authenticated (Subscriber+) Privilege Escalation
The Xelion Webchat plugin for WordPress is vulnerable to Privilege Escalation in all versions up to, and including, 9.1.0. This makes it possible for authenticated attackers, with Subscriber-level access and above, to elevate their privileges to that of an administrator.
CVE-2025-39542 is a high severity with CVSS 8.8 Privilege Escalation issue affecting the Plugin Xelion Webchat. It affects Versions up to 9.1.0 and is fixed in 9.2.0.
CVE-2025-39542 is tracked for the Plugin Xelion Webchat as high severity with CVSS 8.8. The affected range is Versions up to 9.1.0. Update Xelion Webchat to 9.2.0 or newer where that version is compatible with the site.
| Software Type | Plugin |
|---|---|
| Software Slug |
xelion-webchat
View on wordpress.org
|
| CVE | CVE-2025-39542 |
| Patched Versions |
9.2.0
|
| Affected Versions |
Versions up to 9.1.0
|
Related CVEs for Xelion Webchat
These internal links group the same WordPress plugin by CVE, issue type, severity, and patch status so operators and search engines can connect the full vulnerability cluster.
This record contains material that is subject to copyright
License: Defiant hereby grants you a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare derivative works of, publicly display, publicly perform, sublicense, and distribute this software vulnerability information. Any copy of the software vulnerability information you make for such purposes is authorized provided that you include a hyperlink to this vulnerability record and reproduce Defiant's copyright designation and this license in any such copy. Read more
License: CVE Usage: MITRE hereby grants you a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare derivative works of, publicly display, publicly perform, sublicense, and distribute Common Vulnerabilities and Exposures (CVE®). Any copy you make for such purposes is authorized provided that you reproduce MITRE's copyright designation and this license in any such copy. Read more